| Pharmaceutical Information |
| Drug Name |
Adenosine |
| Drug ID |
BADD_D00045 |
| Description |
The structure of adenosine was first described in 1931,[A229823] though the vasodilating effects were not described in literature until the 1940s.[A229828] Adenosine is indicated as an adjunct to thallium-201 in myocardial perfusion scintigraphy,[L31983] though it is rarely used in this indication, having largely been replaced by [dipyridamole] and [regadenson].[A229833,A229838] Adenosine is also indicated in the treatment of supraventricular tachycardia.[L31998]
Adenosine was granted FDA approval on 30 October 1989.[L31978] |
| Indications and Usage |
Adenosine is indicated as an adjunct to thallium-201 in myocardial perfusion scintigraphy in patients unable to adequately exercise.[L31983] It is also indicated to convert sinus rhythm of paroxysmal supraventricular tachycardia.[L31998] |
| Marketing Status |
approved; investigational |
| ATC Code |
C01EB10 |
| DrugBank ID |
DB00640
|
| KEGG ID |
D00045
|
| MeSH ID |
D000241
|
| PubChem ID |
60961
|
| TTD Drug ID |
D06IAR
|
| NDC Product Code |
73590-0037; 73590-0051; 73590-0081; 81758-010; 82083-0008; 82879-0001; 14593-933; 17478-953; 51662-1631; 55150-192; 73590-0034; 73590-0035; 73590-0080; 82083-0007; 17478-542; 71872-7209; 82083-0012; 82083-0018; 82083-0021; 82428-030; 82879-0002; 82879-0003; 0409-1932; 71080-0027; 71872-7099; 67457-857; 71872-7035; 72371-010; 73590-0032; 12562-3021; 25021-318; 51662-1632; 67457-855; 67457-859; 71080-0024; 72078-033; 0641-6113; 73509-020; 73590-0036; 73590-0039; 73590-0079; 58623-0061; 51662-1345; 51662-1450; 67457-856; 68083-156; 72211-004; 73509-010; 73590-0033; 82083-0011; 52584-026; 63323-651; 71759-090; 72371-020; 81689-040; 82428-010; 82879-0005; 23155-258; 42491-1200; 0404-9809; 67457-854; 68083-101; 73509-090; 73590-0048; 17478-544; 51662-1511; 62041-300; 67457-858; 68083-157; 73590-0031; 73590-0040; 73590-0076; 73590-0077; 82083-0009; 16714-556; 25021-301; 42491-1100; 62041-290; 73590-0038; 73590-0054; 73590-0078; 16714-997; 55150-193 |
| UNII |
K72T3FS567
|
| Synonyms |
Adenosine | Adenocard | Adenoscan |
|
| Chemical Information |
| Molecular Formula |
C10H13N5O4 |
| CAS Registry Number |
5536-17-4 |
| SMILES |
C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
